This mechanism, which involves EZH2, holds promise as a potential avenue for the development of strategies aimed at effectively managing the progression and metastasis of HNSCC by targeting EZH2/PRC2 (Fig. 5). Here, EZH2 is linked to head and neck squamous cell carcinoma.